161 related articles for article (PubMed ID: 11359142)
1. The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma.
Cox C; Teknos TN; Barrios M; Brewer GJ; Dick RD; Merajver SD
Laryngoscope; 2001 Apr; 111(4 Pt 1):696-701. PubMed ID: 11359142
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model.
Cox C; Merajver SD; Yoo S; Dick RD; Brewer GJ; Lee JS; Teknos TN
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):781-5. PubMed ID: 12874082
[TBL] [Abstract][Full Text] [Related]
3. Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma.
Khan MK; Mamou F; Schipper MJ; May KS; Kwitny A; Warnat A; Bolton B; Nair BM; Kariapper MS; Miller M; Brewer G; Normolle D; Merajver SD; Teknos TN
Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):333-8. PubMed ID: 16549755
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer.
Redman BG; Esper P; Pan Q; Dunn RL; Hussain HK; Chenevert T; Brewer GJ; Merajver SD
Clin Cancer Res; 2003 May; 9(5):1666-72. PubMed ID: 12738719
[TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
Brewer GJ; Dick RD; Grover DK; LeClaire V; Tseng M; Wicha M; Pienta K; Redman BG; Jahan T; Sondak VK; Strawderman M; LeCarpentier G; Merajver SD
Clin Cancer Res; 2000 Jan; 6(1):1-10. PubMed ID: 10656425
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
7. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.
Brewer GJ; Merajver SD
Integr Cancer Ther; 2002 Dec; 1(4):327-37. PubMed ID: 14664727
[TBL] [Abstract][Full Text] [Related]
8. Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice.
Brewer GJ; Ullenbruch MR; Dick R; Olivarez L; Phan SH
J Lab Clin Med; 2003 Mar; 141(3):210-6. PubMed ID: 12624602
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
10. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
Ricker JL; Chen Z; Yang XP; Pribluda VS; Swartz GM; Van Waes C
Clin Cancer Res; 2004 Dec; 10(24):8665-73. PubMed ID: 15623651
[TBL] [Abstract][Full Text] [Related]
11. Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck.
Jaglowski JR; Zagon IS; Stack BC; Verderame MF; Leure-duPree AE; Manning JD; McLaughlin PJ
Cancer Chemother Pharmacol; 2005 Jul; 56(1):97-104. PubMed ID: 15791460
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic and chemopreventive activities of celecoxib in oral carcinoma cell.
Wang Z; Fuentes CF; Shapshay SM
Laryngoscope; 2002 May; 112(5):839-43. PubMed ID: 12150615
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of Molybdenum Trioxide (CAS No. 1313-27-5) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Apr; 462():1-269. PubMed ID: 12587014
[TBL] [Abstract][Full Text] [Related]
14. Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.
Elner SG; Elner VM; Yoshida A; Dick RD; Brewer GJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):299-303. PubMed ID: 15623788
[TBL] [Abstract][Full Text] [Related]
15. Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII).
Khariwala SS; Kjaergaard J; Lorenz R; Van Lente F; Shu S; Strome M
Laryngoscope; 2006 May; 116(5):814-20. PubMed ID: 16652094
[TBL] [Abstract][Full Text] [Related]
16. Prevention and delay in progression of human squamous cell carcinoma of the head and neck in nude mice by stable overexpression of the opioid growth factor receptor.
McLaughlin PJ; Kreiner S; Morgan CR; Zagon IS
Int J Oncol; 2008 Oct; 33(4):751-7. PubMed ID: 18813788
[TBL] [Abstract][Full Text] [Related]
17. Optimization of an orthotopic murine model of head and neck squamous cell carcinoma in fully immunocompetent mice--role of toll-like-receptor 4 expressed on host cells.
Vahle AK; Kerem A; Oztürk E; Bankfalvi A; Lang S; Brandau S
Cancer Lett; 2012 Apr; 317(2):199-206. PubMed ID: 22123294
[TBL] [Abstract][Full Text] [Related]
18. KITENIN represents a more aggressive phenotype in a murine model of oral cavity squamous carcinoma.
Lee JK; Lim SC; Kim HD; Yoon TM; Kim K; Nam JH; Kim HS; Shin MH; Kim KK
Otolaryngol Head Neck Surg; 2010 May; 142(5):747-52.e1-2. PubMed ID: 20416467
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
20. Tetrathiomolybdate is effective in a mouse model of arthritis.
McCubbin MD; Hou G; Abrams GD; Dick R; Zhang Z; Brewer GJ
J Rheumatol; 2006 Dec; 33(12):2501-6. PubMed ID: 17143984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]